Jump to main content
Jump to site search

Issue 1, 2017
Previous Article Next Article

Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception

Author affiliations

Abstract

It was previously reported that 6β-aminomorphinan derivatives show high affinity for opiate receptors. Novel 6β-heteroarylamidomorphinanes were designed based on the MOR selective antagonist NAP. The 6β-aminomorphinanes were prepared by stereoselective Mitsunobu reaction and subsequently acylated with nicotinic acid and isonicotinic acid chloride hydrochlorides. The receptor binding and efficacy were determined in vitro and the analgesic activity was studied in vivo. The in vitro studies revealed moderate selectivity for the MOR. At least two compounds in this series exhibited a long-lasting analgesic response when administered subcutaneously and intracerebroventricularly. When the substances were given intracerebroventricularly to mice, they showed analgesic potency comparable to morphine.

Graphical abstract: Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 03 Aug 2016, accepted on 04 Oct 2016 and first published on 18 Oct 2016


Article type: Research Article
DOI: 10.1039/C6MD00450D
Citation: Med. Chem. Commun., 2017,8, 152-157
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception

    Á. Urai, A. Váradi, L. Szőcs, B. Komjáti, V. Le Rouzic, A. Hunkele, G. W. Pasternak, S. Majumdar and S. Hosztafi, Med. Chem. Commun., 2017, 8, 152
    DOI: 10.1039/C6MD00450D

Search articles by author